Related Experiment Video
Updated: Aug 10, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Combination therapy for disseminated strongyloidiasis with associated vancomycin-resistant, linezolid-intermediate
Morgan A Tobin1, David F Dougherty2, Patrick D Ratliff1
1Department of Pharmacy Services, Saint Joseph Hospital, Lexington, KY, USA.
What Is Known And Objective:
The rhabditid nematode Strongyloides stercoralis is the major causative agent of disseminated strongyloidiasis (DS). In rare cases, DS has caused enterococcal meningitis. If DS-associated vancomycin-resistant Enterococcus faecium (VRE) meningitis is suspected, combination antibiotic therapy should be considered.
Case Summary:
We present a case of a 61-year-old male who developed DS associated with vancomycin-resistant and linezolid-intermediate E. faecium meningitis after receiving corticosteroids. The VRE meningitis was treated with high-dose daptomycin 12 mg/kg, linezolid, tigecycline and quinupristin/dalfopristin. Despite negative cultures, the patient expired.
What Is New And Conclusion:
In patients with DS-associated VRE meningitis, early use of combination therapy may be warranted to improve patient outcomes.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Endocarditis III: Medical Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Antimicrobial Effectiveness
Rocky Mountain Spotted Fever
Cryptococcal Meningitis

